Westpac Banking Corp
WBC
Woodside Energy Group Ltd
WDS
CommBank
CBA
ANZ Group Holdings Ltd
ANZ
National Australia Bank Ltd
NAB
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.